Key Statistics for YPSN
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (CHF) (ttm)
|Est. EPS (CHF) (03/2014)
|Est. PEG Ratio
|Market Cap (M CHF)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (CHF)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for YPSN
- Net Income (M/CHF)
Ypsomed Holding AG is the holding company for Ypsomed Selfcare solutions, which develops and manufactures custom-made injection systems for pharmaceutical and bio-technology companies. The systems are used by patients for the self administration of drugs. Ypsomed's products include injection pens, pen needles and motor-powered injectors.
More Company Profile & Key Executives for YPSN
|Willy MichelChairman/CEO||Niklaus RamseierChief Financial Officer|
|Hans Ulrich LehmannSenior VP:Technology||Benjamin ReinmannSenior VP:Operations|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.